Delta-like 1 homologue (DLK1) predicts clinical outcomes in patients with hepatocellular carcinoma.
- DOI
- 10.1016/j.jfma.2026.01.022
- Published
- 2026 Jan 21
- Container
- Journal of the Formosan Medical Association = Taiwan yi zhi
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jfma.2026.01.022,
title = {Delta-like 1 homologue (DLK1) predicts clinical outcomes in patients with hepatocellular carcinoma.},
author = {Huang KF and Chu TH and Chang KC and Wu CK and Tsai MC and Huang CC and Hu TH and Tai MH},
year = {2026},
journal = {Journal of the Formosan Medical Association = Taiwan yi zhi},
doi = {10.1016/j.jfma.2026.01.022},
url = {https://doi.org/10.1016/j.jfma.2026.01.022}
}RIS
TY - JOUR TI - Delta-like 1 homologue (DLK1) predicts clinical outcomes in patients with hepatocellular carcinoma. AU - Huang KF AU - Chu TH AU - Chang KC AU - Wu CK AU - Tsai MC AU - Huang CC AU - Hu TH AU - Tai MH PY - 2026 JO - Journal of the Formosan Medical Association = Taiwan yi zhi DO - 10.1016/j.jfma.2026.01.022 UR - https://doi.org/10.1016/j.jfma.2026.01.022 ER -
APA
KF, H., TH, C., KC, C., CK, W., MC, T., CC, H., TH, H., & MH, T. (2026). Delta-like 1 homologue (DLK1) predicts clinical outcomes in patients with hepatocellular carcinoma.. Journal of the Formosan Medical Association = Taiwan yi zhi. https://doi.org/10.1016/j.jfma.2026.01.022
Source records
- pubmed · retrieved 2026-09-26T08:43:41.066Z